BridgeBio has demonstrably advanced the progress of a new treatment for ATTR-CM, utilizing the compound. Initial clinical results indicates significant improvements for individuals suffering by the severe disease. The https://attruby410089.blogsumer.com/40974421/firm-progresses-attr-cm-management-with-the-drug